Carbapenem-nonsusceptible Enterobacteriaceae in Taiwan

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Wang, Jann Tay ^a   Wu, Un In ^a   Lauderdale, Tsai Ling Yang ^b   Chen, Mei Chen ^b   Li, Shu Ying ^c   Hsu, Le Yin ^d   Chang, Shan Chwen ^a,e  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c CENTER FOR DISEASE CONTROL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE AMPC; CARBAPENEM; CEFEPIME; CEFOTAXIME; COLISTIN; ERTAPENEM; FLOMOXEF; IMIPENEM; MEROPENEM; TIGECYCLINE; ANTIINFECTIVE AGENT; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

AGAR DILUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CITROBACTER FREUNDII; CLONAL VARIATION; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; GENETIC SIMILARITY; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RAOULTELLA PLANTICOLA; TAIWAN; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GENETICS; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYLOGENY; PREVALENCE; SPECIES DIFFERENCE;

CITROBACTER FREUNDII; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; RAOULTELLA PLANTICOLA;

ANTI-INFECTIVE AGENTS; BETA-LACTAMASES; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GENES, BACTERIAL; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; PHYLOGENY; PREVALENCE; SPECIES SPECIFICITY; TAIWAN;

EID: 84926332367     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121668     Document Type: Article

References (49)

1. Wauters G, Vaneechoutte M. Approach to the identification of aerobic Gram-negative bacteria. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW, editors. Manual of Clinical Microbiology. Washington, DC: ASM press; 2011. pp. 539-548.
2. Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Control. 2006; 34: S20-S28. PMID: 16813978
3. Pfeifer Y, Cullik A, Witte W. Resistant to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int J Med Microbiol. 2010; 300: 371-379. doi: 10.1016/j.ijmm.2010.04.005 PMID: 20537585
4. Jacoby GA. Extended-spectrum β-lactamases and other enzymes providing resistance to oxyimino-β-lactams. Infect Dis Clin North Am. 1997; 11: 875-887. PMID: 9421705
5. Livermore DM. Has the era of untreatable infections arrived?" J Antimicrob Chemother. 2009; 64: i29-i36. doi: 10.1093/jac/dkp255 PMID: 19675016
6. Yang K, Guglielmo BJ. Diagnosis and treatme of extended-spectrum and AmpC beta-lactamase-producing organisms. Ann Pharmacother. 2007; 41: 1427-1435. PMID: 17666573
7. Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007; 20: 440-458. PMID: 17630334
8. Livermore DM, Hope R, Brick G, Lillie M, Reynolds R; BSAC Working Parties on Resistance Surveillance. Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother. 2008; 62: ii41-ii54. doi: 10.1093/jac/dkn351 PMID: 18819979
9. Bush K. Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr Opin Mirobiol. 2010; 13: 558-564. doi: 10.1016/j.mib.2010.09.006 PMID: 20920882
10. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010; 10: 597-602. doi: 10.1016/S1473-3099(10)70143-2 PMID: 20705517
11. Bonomo RA. New Delhi metallo-β-lactamase and multidrug resistance: a global SOS? Clin Infect Dis. 2011; 52: 485-487. doi: 10.1093/cid/ciq179 PMID: 21258101
12. Cornaglia G, Giamarellou H, Rossolini GM. Metallo-β-lactamases: a last frontier for β-lactams? Lancet Infect Dis. 2011; 11: 381-393. doi: 10.1016/S1473-3099(11)70056-1 PMID: 21530894
13. Livermore DM, Warner M, Mushtaq S, Doumith M, Zhang J, Woodford N. What remains against carba-penem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin, and tigecycleine. Int J Antimicrob Agents. 2011; 37: 415-419. doi: 10.1016/j.ijantimicag.2011.01.012 PMID: 21429716
14. Canton R, Akova M, Cameli Y, Giske CG, Glupczynski Y, Gniadkowski M, et al. Rapid evolution and spread of carbapenemases and Enterobacteriaceae in Europe. Clin Microbiol Infect. 2012; 18: 413-431. doi: 10.1111/j.1469-0691.2012.03821.x PMID: 22507109
15. Poirel L, Pitout JD, Nordmann P. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol. 2007; 2: 501-502. PMID: 17927473
16. Liu YF, Yan JJ, Ko WC, Tsai SH, Wu JJ. Characterization of carbapenem-non-susceptible Escherichia coli isolates from a university hospital in Taiwan. J Antimicrob Chemother. 2008; 61: 1020-1023. doi: 10.1093/jac/dkn049 PMID: 18292097
17. Lee CH, Su LH, Li CC, Chien CC, Tang YF, Liu JW. Microbiologic and clinical implications of bacteremia due to extended-spectrum-beta-lactamse-producing Klebsiella pneumoniae with or without plasmid-mediated AmpC beta-lactamase DHA-1. Antimcirob Agents Chemother. 2010; 54: 5395-5398. doi: 10.1128/AAC.00083-10 PMID: 20855742
18. Yang FC, Yan JJ. Characterizaton of ertapenem-resistant Enterobacter cloacae in a Taiwanese university hospital. J Clin Microbiol. 2012; 50: 223-226. doi: 10.1128/JCM.01263-11 PMID: 22135256
19. Ma L, Lu PL, Siu LK, Hsieh MH. Molecular typing and resistance mechanisms of imipenem-non-susceptible Klebsiella pneumoniae in Taiwan: results from the Taiwan Surveillance of Antibiotic Resistance (TSAR) study, 2002-2009. J Med Microbiol. 2013; 62: 101-107. doi: 10.1099/jmm.0.050492-0 PMID: 23002067
20. Sheng WH, Badal RE, Hsueh PR, SMART Program. Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intrabdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicribial Resistance Trends (SMART). Antimicrob Agents Chemother. 2013; 57: 2981-2988. doi: 10.1128/AAC. 00971-12 PMID: 23587958
21. nd informational supplement M100-S22. Wayne, PA: CLSI; 2012.
22. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: appoved standard - eighth edition M07-A8. Wayne, PA: CLSI; 2009. doi: 10.1016/j.diagmicrobio.2013.01.001.Antimicrobial PMID: 23514757
23. European Committee on Antimicrobial Susceptibilities Testing (EUCAST) Breakpoint tables for interpretation of MICs and zone diameters. EUCAST. 2014. Available: http://www.eucast.org/fileadmin/src/ media/PDFs/EUCAST-files/Breakpoint-tables/Breakpoint-table-v-4.0.pdf. Accessed 9 September 2014.
24. Liao CH, Sheng WH, Wang JT, Sun HY, Wang HK, Hsueh PR, et al. In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan. J Microbiol Immunol Infect. 2006; 39: 59-66. PMID: 16440125
25. Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamse genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002; 40: 2153-2162. PMID: 12037080
26. Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamses. J Antimicrob Chemother. 2006; 57: 154-155. PMID: 16284100
27. CTX-M genes in Enterobacteriaceae. APMIS. 2007; 115: 1400-1408. doi: 10.1111/j.1600-0463.2007.00722.x PMID: 18184411
28. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005; 43: 4178-4182. PMID: 16081970
29. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005; 63:219-228. PMID: 15935499
30. O'Brien TF, Stelling J. Integrated multilevel surveillance of the world's infecting microbes and their resistance to antimicrobial agents. Clin Microbiol Rev. 2011; 24: 281-295. doi: 10.1128/CMR.00021-10 PMID: 21482726
31. nd informational supplement M100-S19. Wayne, PA: CLSI; 2009.
32. Tzouvelekis LS, Markoglannakis A, Psichoglou M, Tassios PT, Dalkos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012; 25: 682-707. doi: 10.1128/CMR.05035-11 PMID: 23034326
33. Ma L, Siu LK, Lin JC, Wu TL, Fung CP, Wang JT, et al. Updated molecular epidemiology of carbapenem-non-susceptible Escherichia coli in Taiwan: first identification of KPC-2 or NDM-1-producing E. coli in Taiwan. BMC Infect Dis. 2013; 13: 599. doi: 10.1186/1471-2334-13-599 PMID: 24354657
34. Chiu SK, Wu TL, Chuang YC, Lin JC, Fung CP, Lu PL, et al. National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemase. PLoS One. 2013; 8: e69428. doi: 10.1371/journal.pone.0069428 PMID: 23894478
35. Lee CM, Liao CH, Lee WS, Liu YC, Mu JJ, Lee MC, et al. Outbreak of Klebsiella pneumoniae carbapenemase-2-producing K. pneumoniae sequence type 11 in Taiwan in 2011. Antimicrob Agents Chemother. 2012; 56: 5016-5022. doi: 10.1128/AAC.00878-12 PMID: 22802253
36. Chung KP, Tseng SP, Huang YC, Tsai TH, Teng LJ, Hsueh PR. Arrival of Klebsiella pneumoniae carbapenemase (KPC)-2 in Taiwan. J Antimicrob Chemother. 2011; 66: 1182-1184. doi: 10.1093/jac/dkr025 PMID: 21393195
37. NDM-1-positive Klebsiella oxytoca isolate from Taiwan. Antimicrob Agents Chemother. 2013; 57: 4072-4076. doi: 10.1128/AAC.02266-12 PMID: 23752513
38. Yan JJ, Ko WC, Chuang CL, Wu JJ. Metallo-beta-lactamse-producing Enterobacteriaceae isolates in a university hospital in Taiwan: prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii. J Antimicrob Chemother. 2002; 50: 503-511. PMID: 12356794
39. Hayakawa K, Mlyoshi-Akiyama T, Kirikae T, Nagamatsu M, Shimada K, Mezaki K, et al. Molecular and epidemiological characterization of IMP-type metallo-β-lactamase-producing Enterobacter cloacae in a large tertiary care hospital in Japan. Antimicrob Agents Chemother. 2014; 58: 3441-3450. doi: 10.1128/AAC.02652-13 PMID: 24709261
40. Hu AY, Leslie KA, Baskette J, Elsayed S. Raoultella planticola bacteremia. J Med Microbiol. 2012; 61: 1488-1489. doi: 10.1099/jmm.0.041129-0 PMID: 22820690
41. Teo I, Wild J, Ray S, Chadwick D. A rare case of cholecystitis caused by Raoultella planticola. Case Rep Med. 2012; 2012: 601641. doi: 10.1155/2012/601641 PMID: 22690225
42. Olson DS Jr, Asare K, Lyons M, Hofinger DM. A novel case of Raoultella planticola urinary tract infection. Infection. 2013; 41: 259-261. doi: 10.1007/s15010-012-0294-x PMID: 22802099
43. Trevino M, Moldes l, Martinez-Lamas L, Varon C, Regueiro BJ. Carbapenem-resistant Enterobacter cloacae and the emergence of metallo-β-lactamase-producing strains in a third-level hospital (Santiago de Compostela, NW Spain). Eur J Clin Microbiol Infect Dis. 2009; 28: 1253-1258. doi: 10.1007/ s10096-009-0765-x PMID: 19504135
44. Endimiani A, Perez F, Bajaksouzian S, Windau AR, Good CE, Choudhary Y, et al. Evaluation of updated interpretative criteria for categorizing Klebsiella pneumoniae with reduced carbapenem susceptibility. J Clin Microbiol. 2010; 48: 4417-4425. doi: 10.1128/JCM.02458-09 PMID: 20881179
45. Centers for Disease Control and Prevention (CDC). Guidance for control of carbapenem-resistant Enterobacteriaceae (CRE). CDC. 2012. Available: http://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf.
46. Szabo D, Silveira F, Hujer AM, Bonomo RA, Hujer KM, Mujer KM, et al. Outer membrane protein changes and efflux pump expression together may confer resistance to ertapenem in Enterobacter cloacae. Antimicrob Agents Chemother. 2006; 50: 2833-2835. PMID: 16870780
47. Yan JJ, Wu JJ, Lee CC, Ko WC, Yang FC. Prevalene and characteristics of ertapenem-nonsusceptible Escherichia coli in a Taiwanese university hospital, 1999 to 2007. Eur J Clin Microbiol Infet Dis. 2010; 29: 1417-1425. doi: 10.1007/s10096-010-1020-1 PMID: 20700614
48. Doumith M, Ellington M, Livermore DM, Woodford N. Molecular mechanisms distupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. Clinical isolates from the UK. J Antimicrob Chemother. 2009; 63: 659-667. doi: 10.1093/jac/dkp029 PMID: 19233898
49. Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother. 2009; 64: i3-i10. doi: 10.1093/jac/dkp256 PMID: 19675017